文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在台湾,下肢外周动脉疾病的侵袭性治疗发生率及相关因素:2000-2011 年全国住院数据分析。

Invasively-treated incidence of lower extremity peripheral arterial disease and associated factors in Taiwan: 2000-2011 nationwide hospitalized data analysis.

机构信息

Department of Medical Research, Taoyuan General Hospital, Ministry of Health & Welfare, Taoyuan, Taiwan.

出版信息

BMC Public Health. 2013 Dec 1;13:1107. doi: 10.1186/1471-2458-13-1107.


DOI:10.1186/1471-2458-13-1107
PMID:24289250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4219520/
Abstract

BACKGROUND: Lower extremity (LE) peripheral artery disease (PAD), which is associated with a reduced quality of life and increased mortality from atherosclerotic cardio-/cerebro-vascular occlusion, is a significant public health problem, especial for an aging society such as that of Taiwan. METHODS: Specific datasets of the 2000-2011 nationwide inpatient databases were analyzed. Two inclusion criteria, including one of the major diagnosis codes of PAD and one of three categorical invasive treatments of LE PAD, were used consecutively to select cases diagnosed as LE PAD and receiving invasive treatment. The epidemiology of invasively-treated PAD in Taiwan was estimated, and the influences of potential confounders on these invasively-treated methods were evaluated. RESULTS: In general, the invasively-treated incidence of PAD in Taiwan doubled, from 3.73/10,000 (in 2000) to 7.48/10,000 (in 2011). On average, the total direct medical cost of one hospitalized and invasively-treated PAD case ranged from $US 4,600 to $US 5,900. The annual cases of bypass surgery for the PAD cases averaged 1,000 and the cases for limb amputation ranged from 4,100 to 5,100 annually. However, the number of percutaneous transluminal angioplasty (PTA) procedures remarkably increased by 15 times, from 600/year to 9,100/year, from 2000 to 2011. 51.3% of all the enrolled cases were treated with limb amputations, and female, young and middle-aged people (30-65 years of age), DM patients and those on a low income had a tendency to undergo amputation due to PAD. 37.6% of all the enrolled cases were treated with PTAs related to hypertension, cardiovascular disease, hyperlipidemia and catastrophic Illness. 2-year PTA failure rates of 22.13%, 11.91% and 10.61% were noted among the first (2000-2001), second (2004-2005) and the third (2008-2009) cohort groups, respectively. CONCLUSIONS: In Taiwan, a gender difference and age and period effects on the invasively-treated incidence of LE PAD were observed. Female, young and middle-aged people (30-50 and 50-65 years of age), DM patients and those on a low income had a tendency to undergo amputation. The number of PTA procedures remarkably increased, but the 2-year failure rate of PTAs reduced from 2000 to 2011.

摘要

背景:下肢动脉疾病(PAD)会降低生活质量,并增加动脉粥样硬化性心脑血管闭塞导致的死亡率,是一个严重的公共卫生问题,尤其是在像台湾这样的老龄化社会。

方法:分析了 2000 年至 2011 年全国住院患者数据库的特定数据集。连续使用两个纳入标准,包括 PAD 的主要诊断代码之一和下肢 PAD 的三种分类侵入性治疗之一,以选择诊断为下肢 PAD 并接受侵入性治疗的病例。估计了台湾接受侵入性治疗的 PAD 的流行病学,并评估了潜在混杂因素对这些侵入性治疗方法的影响。

结果:总体而言,台湾接受侵入性治疗的 PAD 发病率增加了一倍,从 2000 年的 3.73/10000 增加到 2011 年的 7.48/10000。平均而言,每位住院接受侵入性治疗的 PAD 患者的直接医疗费用在 4600 美元至 5900 美元之间。PAD 患者每年进行旁路手术的病例平均为 1000 例,截肢病例每年从 4100 例到 5100 例不等。然而,经皮腔内血管成形术(PTA)的数量却显著增加了 15 倍,从 2000 年的 600 例/年增加到 9100 例/年。所有纳入病例中,51.3%接受了截肢治疗,女性、年轻和中年(30-65 岁)、糖尿病患者和低收入者因 PAD 有截肢的倾向。所有纳入病例中,有 37.6%接受了与高血压、心血管疾病、高血脂和灾难性疾病相关的 PTA 治疗。第一(2000-2001 年)、第二(2004-2005 年)和第三(2008-2009 年)队列组中,2 年 PTA 失败率分别为 22.13%、11.91%和 10.61%。

结论:在台湾,观察到下肢 PAD 接受侵入性治疗的发病率存在性别差异和年龄和时期效应。女性、年轻和中年(30-50 岁和 50-65 岁)、糖尿病患者和低收入者有截肢的倾向。PTA 手术数量显著增加,但 2000 年至 2011 年,PTA 的 2 年失败率有所下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/50d0cae8e3db/1471-2458-13-1107-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/0bea49e5097d/1471-2458-13-1107-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/ff04c06e2e46/1471-2458-13-1107-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/50d0cae8e3db/1471-2458-13-1107-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/0bea49e5097d/1471-2458-13-1107-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/ff04c06e2e46/1471-2458-13-1107-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc90/4219520/50d0cae8e3db/1471-2458-13-1107-3.jpg

相似文献

[1]
Invasively-treated incidence of lower extremity peripheral arterial disease and associated factors in Taiwan: 2000-2011 nationwide hospitalized data analysis.

BMC Public Health. 2013-12-1

[2]
Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data.

J Vasc Surg. 2016-12

[3]
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Ont Health Technol Assess Ser. 2010

[4]
Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases.

Cardiovasc Diabetol. 2019-11-15

[5]
Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease.

Int J Cardiol. 2012-7-11

[6]
Stent revascularization versus bypass surgery for peripheral artery disease in type 2 diabetic patients - an instrumental variable analysis.

Sci Rep. 2016-11-18

[7]
Trends in Lower Limb Amputation in Patients with Diabetic Foot Based on Vascular Intervention of Peripheral Arterial Disease in Korea: a Population-based Nationwide Study.

J Korean Med Sci. 2019-7-8

[8]
Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies.

Osteoporos Int. 2017-8-18

[9]
Sex Differences in Outcomes Following Endovascular Treatment for Symptomatic Peripheral Artery Disease: An Analysis From the K- VIS ELLA Registry.

J Am Heart Assoc. 2019-1-22

[10]
Amputation Risk in Patients with Diabetes Mellitus and Peripheral Artery Disease Using Statewide Data.

Ann Vasc Surg. 2016-1

引用本文的文献

[1]
Systemic outcomes of symptomatic peripheral artery disease patients with end-stage renal disease undergoing lower limb endovascular treatment: a propensity score-matched analysis.

BMC Cardiovasc Disord. 2025-5-21

[2]
Referral, Diagnosis, and Pharmacological Management of Peripheral Artery Disease: Perspectives from Taiwan.

Acta Cardiol Sin. 2023-1

[3]
Integrative Therapy Combining Chinese Herbal Medicines With Conventional Treatment Reduces the Risk of Cardiovascular Disease Among Patients With Systemic Lupus Erythematosus: A Retrospective Population-Based Cohort Study.

Front Pharmacol. 2021-9-27

[4]
CHADS-VASc Score and Risk of New-Onset Peripheral Arterial Occlusive Disease in Patients without Atrial Fibrillation.

Acta Cardiol Sin. 2021-5

[5]
Lower extremity arterial interventions in England.

Ann R Coll Surg Engl. 2021-5

[6]
Antithrombotic Treatment for Symptomatic Peripheral Artery Disease.

Acta Cardiol Sin. 2019-11

[7]
Hemorrhoid is associated with increased risk of peripheral artery occlusive disease: A nationwide cohort study.

J Epidemiol. 2017-12

[8]
Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study.

Medicine (Baltimore). 2016-8

[9]
Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study.

Medicine (Baltimore). 2015-12

[10]
National trends for the treatment of peripheral arterial disease in Korea between 2004 and 2013.

Ann Surg Treat Res. 2015-12

本文引用的文献

[1]
Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan.

PLoS One. 2013-5-22

[2]
Comparisons of medical utilizations and categorical diagnoses of emergency visits between the elderly with catastrophic illness certificates and those without.

BMC Health Serv Res. 2013-4-26

[3]
Prevalence of asymptomatic peripheral arterial disease and related risk factors in younger and elderly patients in Taiwan.

Angiology. 2013-3-18

[4]
[Quality of life and burden of disease in peripheral arterial disease: a study among Hungarian patients].

Orv Hetil. 2013-3-24

[5]
A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial.

J Am Coll Cardiol. 2012-12-4

[6]
Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008.

J Am Coll Cardiol. 2012-10-24

[7]
Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

JAMA. 2012-10-24

[8]
Peripheral arterial disease: a literature review.

Br Med Bull. 2012-10-18

[9]
Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan.

BMC Nephrol. 2012-9-3

[10]
Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.

Int J Angiol. 2007

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索